The risk of clinically diagnosed gout by serum urate levels: results from 30 years follow-up of the Malmö Preventive Project cohort in southern Sweden
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6362
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The risk of clinically diagnosed gout by serum urate levels: results from 30 years follow-up of the Malmö Preventive Project cohort in southern Sweden ; volume:20 ; number:1 ; day:29 ; month:8 ; year:2018 ; pages:1-10 ; date:12.2018
Arthritis Research & Therapy ; 20, Heft 1 (29.8.2018), 1-10, 12.2018
- Creator
-
Kapetanovic, Meliha C.
- Contributor
-
Nilsson, Peter
Turesson, Carl
Englund, Martin
Dalbeth, Nicola
Jacobsson, Lennart
SpringerLink (Online service)
- DOI
-
10.1186/s13075-018-1697-6
- URN
-
urn:nbn:de:101:1-2018102511132760636679
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kapetanovic, Meliha C.
- Nilsson, Peter
- Turesson, Carl
- Englund, Martin
- Dalbeth, Nicola
- Jacobsson, Lennart
- SpringerLink (Online service)
Other Objects (12)
Variation in serum urate levels in the absence of gout and urate lowering therapy
Adherence with urate-lowering therapies for the treatment of gout
Urate-lowering therapy, serum urate, inflammatory biomarkers, and renal function in patients with gout following pegloticase discontinuation
The absolute risk of gout by clusters of gout-associated comorbidities and lifestyle factors—30 years follow-up of the Malmö Preventive Project
The renal urate transporter SLC17A1 locus: confirmation of association with gout
The relationship between ferritin and urate levels and risk of gout
Unraveling the pathological biomineralization of monosodium urate crystals in gout patients
Fluctuation and change of serum urate levels and flares in gout: results from the NOR-Gout study
In vivo study of newly developed albumin-conjugated urate oxidase for gout treatment
Untangling the complex relationships between incident gout risk, serum urate, and its comorbidities
Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout
Prognostic factors associated with early gout flare recurrence in patients initiating urate-lowering therapy during an acute gout flare
Variation in serum urate levels in the absence of gout and urate lowering therapy
Adherence with urate-lowering therapies for the treatment of gout
Urate-lowering therapy, serum urate, inflammatory biomarkers, and renal function in patients with gout following pegloticase discontinuation
The absolute risk of gout by clusters of gout-associated comorbidities and lifestyle factors—30 years follow-up of the Malmö Preventive Project
The renal urate transporter SLC17A1 locus: confirmation of association with gout
The relationship between ferritin and urate levels and risk of gout
Unraveling the pathological biomineralization of monosodium urate crystals in gout patients
Fluctuation and change of serum urate levels and flares in gout: results from the NOR-Gout study
In vivo study of newly developed albumin-conjugated urate oxidase for gout treatment
Untangling the complex relationships between incident gout risk, serum urate, and its comorbidities
Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout
Prognostic factors associated with early gout flare recurrence in patients initiating urate-lowering therapy during an acute gout flare
Variation in serum urate levels in the absence of gout and urate lowering therapy
Adherence with urate-lowering therapies for the treatment of gout
Urate-lowering therapy, serum urate, inflammatory biomarkers, and renal function in patients with gout following pegloticase discontinuation
The absolute risk of gout by clusters of gout-associated comorbidities and lifestyle factors—30 years follow-up of the Malmö Preventive Project
The renal urate transporter SLC17A1 locus: confirmation of association with gout
The relationship between ferritin and urate levels and risk of gout
Unraveling the pathological biomineralization of monosodium urate crystals in gout patients
Fluctuation and change of serum urate levels and flares in gout: results from the NOR-Gout study
In vivo study of newly developed albumin-conjugated urate oxidase for gout treatment
Untangling the complex relationships between incident gout risk, serum urate, and its comorbidities
Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout